ginsenoside rh2 has been researched along with Experimental Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HF; Chen, QC; Li, W; Lin, T; Liu, WC; Wei, GQ; Zeng, JZ; Zhang, WY; Zhang, XK; Zheng, YN | 1 |
Liu, FG; Zhang, WY; Zheng, YN | 1 |
Bu, X; Bush, JA; Chen, X; Jia, WW; Li, G; Liu, G; Philips, D; Yan, H | 1 |
3 other study(ies) available for ginsenoside rh2 and Experimental Neoplasms
Article | Year |
---|---|
Structural modification of ginsenoside Rh(2) by fatty acid esterification and its detoxification property in antitumor.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Esters; Fatty Acids; Ginsenosides; Humans; Mice; Mice, Inbred Strains; Molecular Conformation; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Spleen; Structure-Activity Relationship; Thymus Gland; Xenograft Model Antitumor Assays | 2012 |
[Synthesis and anti-tumor activity of ginsenoside Rh_2 caprylic acid monoester].
Topics: Animals; Caprylates; Ginsenosides; Mice; Molecular Structure; Neoplasms, Experimental; Saponins | 2019 |
Rh2, a compound extracted from ginseng, hypersensitizes multidrug-resistant tumor cells to chemotherapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Ginsenosides; Humans; Mice; Mice, Inbred C57BL; Mitoxantrone; Neoplasm Transplantation; Neoplasms, Experimental; Paclitaxel; Panax; Plant Extracts; Receptors, Glucocorticoid; Tumor Suppressor Protein p53 | 2004 |